Pharmacy Research Showcase highlights Digital medicines decisions are often made without good evidence, and pharmacy researchers could help fill that gap. That was the challenge Rahul Singal, Chief… read more.
Pharmacy Research Showcase highlights How can a trust make research a normal part of pharmacy work rather than an optional extra? Jatinder Harchowal MBE, Chief Pharmacist and Divisional… read more.
A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced… read more.
Plozasiran can be used as an option to treat genetically confirmed familial chylomicronaemia syndrome in adults, only if response to diet and conventional triglyceride-lowering treatments (such as statins… read more.
Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy… read more.
AbbVie announced the U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen for Skyrizi (risankizumab-rzaa) for adults with moderately to severely active Crohn’s disease (CD)…. read more.
Eton Pharmaceuticals, Inc. (“Eton”) and Aquestive Therapeutics, Inc. (“Aquestive”) announced that they have entered into an exclusive license agreement and a supply agreement covering the United States and… read more.
ALK announced positive topline results from the phase 3 bridging trial evaluating the efficacy and safety of its house dust mite (‘HDM’) sublingual immunotherapy (‘SLIT’) tablet, Acarizax, in… read more.
Johnson & Johnson announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given for six… read more.
Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. This indication… read more.
Pharmacy Research Showcase highlights Research as part of every pharmacy career Research should be part of the routine work for every pharmacist and pharmacy technician, not a specialist… read more.
Pharmacy Research Showcase highlights Some £5 billion per year are spent on UK healthcare research; only a small proportion of that goes into pharmacy research despite the fact… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
